Sandoz Inc Drug Patent Portfolio

Drug Patent Number Drug Patent Title Drug Patent Expiry Status


Sandoz Inc's Family Patents


Family Patents



Sandoz Inc Drug List

Given below is the complete list of Sandoz Inc's drugs and the patents protecting them.


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Sandoz Inc News

FDA grants approval to Fresenius Kabi for biosimilar of Stelara called Otulfi, announces Pharmaceutical Technology

01 Oct, 2024

Court rejects Regeneron's request to stop production of generic version of popular eye medication

24 Sep, 2024

Sandoz to Introduce First Generic GLP1 Drug in Canadian Market by 2026 - SWI swissinfo.ch

04 Sep, 2024

Sandoz Sets to Release First Generic GLP1 Drug in Canada in 2026, as Reported by BNN Bloomberg

03 Sep, 2024

See More